Postmastectomy Radiation Therapy (PMRT) before and after 2-Stage Expander-Implant Breast Reconstruction: A Systematic Review
Authors:
- Jeremie D. OliverJOJeremie D. Oliver
- Daniel BoczarDBDaniel Boczar
- Maria T. HuayllaniMHMaria T. Huayllani
- David J. RestrepoDRDavid J. Restrepo
- Andrea SistiAndrea Sisti
- Oscar J. ManriqueOMOscar J. Manrique
- Peter Niclas BroerPeter Niclas Broer
- Sarah McLaughlinSMSarah McLaughlin
- Brian D. RinkerBRBrian D. Rinker
- Antonio Jorge ForteAntonio Jorge Forte
Open Access
Abstract
Background: In those undergoing treatment for breast cancer, evidence has demonstrated a significant improvement in survival, and a reduction in the risk of local recurrence in patients who undergo postmastectomy radiation therapy (PMRT). There is uncertainty about the optimal timing of PMRT, whether it should be before or after tissue expander or permanent implant placement. This study aimed to summarize the data reported in the literature on the effect of the timing of PMRT, both preceding and following 2-stage expander-implant breast reconstruction (IBR), and to statistically analyze the impact of timing on infection rates and the need for explantation. Methods: A comprehensive systematic review of the literature was conducted using the PubMed/Medline, Ovid, and Cochrane databases without timeframe limitations. Articles included in the analysis were those reporting outcomes data of PMRT in IBR published from 2009 to 2017. Chi-square statistical analysis was performed to compare infection and explantation rates between the two subgroups at p < 0.05. Results: A total of 11 studies met the inclusion criteria for this study. These studies reported outcomes data for 1565 total 2-stage expander-IBR procedures, where PMRT was used (1145 before, and 420 after, implant placement). There was a statistically significant higher likelihood of infection following pre-implant placement PMRT (21.03%, p = 0.000079), compared to PMRT after implant placement (9.69%). There was no difference in the rate of explantation between pre-implant placement PMRT (12.93%) and postimplant placement PMRT (11.43%). Conclusion: This study suggests that patients receiving PMRT before implant placement in 2-stage expander–implant based reconstruction may have a higher risk of developing an infection.Keywords
Funding Information
- This study was supported in part by the Mayo Clinic Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery (N/A)
This publication has 44 references indexed in Scilit:
- The Effects of Postmastectomy Adjuvant Radiotherapy on Immediate Two-Stage Prosthetic Breast ReconstructionPlastic and Reconstructive Surgery, 2013
- A Paradigm Shift in U.S. Breast ReconstructionPlastic and Reconstructive Surgery, 2013
- One Decade Later: Trends and Disparities in the Application of Post-Mastectomy Radiotherapy Since the Release of the American Society of Clinical Oncology Clinical Practice GuidelinesInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2012
- Ionizing Radiation: The Good, the Bad, and the UglyJournal of Investigative Dermatology, 2012
- Risk Factors for Complications of Radiation Therapy on Tissue Expander Breast ReconstructionsThe Breast Journal, 2011
- Outcome of Different Timings of Radiotherapy in Implant-Based Breast ReconstructionsPlastic and Reconstructive Surgery, 2011
- Radiotherapy and breast reconstruction: a meta-analysisBreast Cancer Research and Treatment, 2011
- Postmastectomy Chest Wall Radiation to a Temporary Tissue Expander or Permanent Breast Implant—Is There a Difference in Complication Rates?International Journal of Radiation Oncology - Biology - Physics (IJROBP), 2009
- Reduction of radiotherapy-induced late complications in early breast cancer: the role of intensity-modulated radiation therapy and partial breast irradiationClinical Oncology, 2005
- Pathophysiology of irradiated skin and breastInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1995